Polygenic Risk Scores Driving Clinical Change in Glaucoma

Glaucoma is a clinically heterogeneous disease and the world's leading cause of irreversible blindness. Therapeutic intervention can prevent blindness but relies on early diagnosis, and current clinical risk factors are limited in their ability to predict who will develop sight-threatening glau...

Full description

Saved in:
Bibliographic Details
Published in:Annual review of genomics and human genetics 2024-08, Vol.25 (1), p.287-308
Main Authors: Kolovos, Antonia, Hassall, Mark M, Siggs, Owen M, Souzeau, Emmanuelle, Craig, Jamie E
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c1662-e54f4a4ecf8b4911281bf997a0304105dca05fb677a74af9ff2386aa4860db273
cites cdi_FETCH-LOGICAL-c1662-e54f4a4ecf8b4911281bf997a0304105dca05fb677a74af9ff2386aa4860db273
container_end_page 308
container_issue 1
container_start_page 287
container_title Annual review of genomics and human genetics
container_volume 25
creator Kolovos, Antonia
Hassall, Mark M
Siggs, Owen M
Souzeau, Emmanuelle
Craig, Jamie E
description Glaucoma is a clinically heterogeneous disease and the world's leading cause of irreversible blindness. Therapeutic intervention can prevent blindness but relies on early diagnosis, and current clinical risk factors are limited in their ability to predict who will develop sight-threatening glaucoma. The high heritability of glaucoma makes it an ideal substrate for genetic risk prediction, with the bulk of risk being polygenic in nature. Here, we summarize the foundations of glaucoma genetic risk, the development of polygenic risk prediction instruments, and emerging opportunities for genetic risk stratification. Although challenges remain, genetic risk stratification will significantly improve glaucoma screening and management.
doi_str_mv 10.1146/annurev-genom-121222-105817
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3037398954</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3037398954</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1662-e54f4a4ecf8b4911281bf997a0304105dca05fb677a74af9ff2386aa4860db273</originalsourceid><addsrcrecordid>eNo9kFtLAzEQhYMotlb_giz44ks0t90k-CSrVkFQvIBvYTZNanQvNXEL_fdubfVpBuacM4cPoRNKzigVxTm0bR_dEs9d2zWYMsoYw5TkisodNKa5yDHT_G13vTOJFSNihA5S-iCEKCXIPhpxlWs92MZIP3b1akgKNnsK6TN7tl10KbuKYRnaeVbWYThBnZXv0M5dFtpsWkNvuwYO0Z6HOrmj7Zyg15vrl_IW3z9M78rLe2xpUTDscuEFCGe9qoSmlClaea0lEE7E0HpmgeS-KqQEKcBr7xlXBYBQBZlVTPIJOt3kLmL31bv0bZqQrKtraF3XJ8MJl1wrnYtBerGR2tilFJ03ixgaiCtDiVmzM1t25ped2bAzG3aD-3j7qK8aN_v3_sHiPyC4bcs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3037398954</pqid></control><display><type>article</type><title>Polygenic Risk Scores Driving Clinical Change in Glaucoma</title><source>Annual Reviews Open Access</source><creator>Kolovos, Antonia ; Hassall, Mark M ; Siggs, Owen M ; Souzeau, Emmanuelle ; Craig, Jamie E</creator><creatorcontrib>Kolovos, Antonia ; Hassall, Mark M ; Siggs, Owen M ; Souzeau, Emmanuelle ; Craig, Jamie E</creatorcontrib><description>Glaucoma is a clinically heterogeneous disease and the world's leading cause of irreversible blindness. Therapeutic intervention can prevent blindness but relies on early diagnosis, and current clinical risk factors are limited in their ability to predict who will develop sight-threatening glaucoma. The high heritability of glaucoma makes it an ideal substrate for genetic risk prediction, with the bulk of risk being polygenic in nature. Here, we summarize the foundations of glaucoma genetic risk, the development of polygenic risk prediction instruments, and emerging opportunities for genetic risk stratification. Although challenges remain, genetic risk stratification will significantly improve glaucoma screening and management.</description><identifier>ISSN: 1527-8204</identifier><identifier>ISSN: 1545-293X</identifier><identifier>EISSN: 1545-293X</identifier><identifier>DOI: 10.1146/annurev-genom-121222-105817</identifier><identifier>PMID: 38599222</identifier><language>eng</language><publisher>United States</publisher><ispartof>Annual review of genomics and human genetics, 2024-08, Vol.25 (1), p.287-308</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1662-e54f4a4ecf8b4911281bf997a0304105dca05fb677a74af9ff2386aa4860db273</citedby><cites>FETCH-LOGICAL-c1662-e54f4a4ecf8b4911281bf997a0304105dca05fb677a74af9ff2386aa4860db273</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,786,790,27957,27958</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38599222$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kolovos, Antonia</creatorcontrib><creatorcontrib>Hassall, Mark M</creatorcontrib><creatorcontrib>Siggs, Owen M</creatorcontrib><creatorcontrib>Souzeau, Emmanuelle</creatorcontrib><creatorcontrib>Craig, Jamie E</creatorcontrib><title>Polygenic Risk Scores Driving Clinical Change in Glaucoma</title><title>Annual review of genomics and human genetics</title><addtitle>Annu Rev Genomics Hum Genet</addtitle><description>Glaucoma is a clinically heterogeneous disease and the world's leading cause of irreversible blindness. Therapeutic intervention can prevent blindness but relies on early diagnosis, and current clinical risk factors are limited in their ability to predict who will develop sight-threatening glaucoma. The high heritability of glaucoma makes it an ideal substrate for genetic risk prediction, with the bulk of risk being polygenic in nature. Here, we summarize the foundations of glaucoma genetic risk, the development of polygenic risk prediction instruments, and emerging opportunities for genetic risk stratification. Although challenges remain, genetic risk stratification will significantly improve glaucoma screening and management.</description><issn>1527-8204</issn><issn>1545-293X</issn><issn>1545-293X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNo9kFtLAzEQhYMotlb_giz44ks0t90k-CSrVkFQvIBvYTZNanQvNXEL_fdubfVpBuacM4cPoRNKzigVxTm0bR_dEs9d2zWYMsoYw5TkisodNKa5yDHT_G13vTOJFSNihA5S-iCEKCXIPhpxlWs92MZIP3b1akgKNnsK6TN7tl10KbuKYRnaeVbWYThBnZXv0M5dFtpsWkNvuwYO0Z6HOrmj7Zyg15vrl_IW3z9M78rLe2xpUTDscuEFCGe9qoSmlClaea0lEE7E0HpmgeS-KqQEKcBr7xlXBYBQBZlVTPIJOt3kLmL31bv0bZqQrKtraF3XJ8MJl1wrnYtBerGR2tilFJ03ixgaiCtDiVmzM1t25ped2bAzG3aD-3j7qK8aN_v3_sHiPyC4bcs</recordid><startdate>20240827</startdate><enddate>20240827</enddate><creator>Kolovos, Antonia</creator><creator>Hassall, Mark M</creator><creator>Siggs, Owen M</creator><creator>Souzeau, Emmanuelle</creator><creator>Craig, Jamie E</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20240827</creationdate><title>Polygenic Risk Scores Driving Clinical Change in Glaucoma</title><author>Kolovos, Antonia ; Hassall, Mark M ; Siggs, Owen M ; Souzeau, Emmanuelle ; Craig, Jamie E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1662-e54f4a4ecf8b4911281bf997a0304105dca05fb677a74af9ff2386aa4860db273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kolovos, Antonia</creatorcontrib><creatorcontrib>Hassall, Mark M</creatorcontrib><creatorcontrib>Siggs, Owen M</creatorcontrib><creatorcontrib>Souzeau, Emmanuelle</creatorcontrib><creatorcontrib>Craig, Jamie E</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annual review of genomics and human genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kolovos, Antonia</au><au>Hassall, Mark M</au><au>Siggs, Owen M</au><au>Souzeau, Emmanuelle</au><au>Craig, Jamie E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Polygenic Risk Scores Driving Clinical Change in Glaucoma</atitle><jtitle>Annual review of genomics and human genetics</jtitle><addtitle>Annu Rev Genomics Hum Genet</addtitle><date>2024-08-27</date><risdate>2024</risdate><volume>25</volume><issue>1</issue><spage>287</spage><epage>308</epage><pages>287-308</pages><issn>1527-8204</issn><issn>1545-293X</issn><eissn>1545-293X</eissn><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>ObjectType-Review-3</notes><notes>content type line 23</notes><abstract>Glaucoma is a clinically heterogeneous disease and the world's leading cause of irreversible blindness. Therapeutic intervention can prevent blindness but relies on early diagnosis, and current clinical risk factors are limited in their ability to predict who will develop sight-threatening glaucoma. The high heritability of glaucoma makes it an ideal substrate for genetic risk prediction, with the bulk of risk being polygenic in nature. Here, we summarize the foundations of glaucoma genetic risk, the development of polygenic risk prediction instruments, and emerging opportunities for genetic risk stratification. Although challenges remain, genetic risk stratification will significantly improve glaucoma screening and management.</abstract><cop>United States</cop><pmid>38599222</pmid><doi>10.1146/annurev-genom-121222-105817</doi><tpages>22</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1527-8204
ispartof Annual review of genomics and human genetics, 2024-08, Vol.25 (1), p.287-308
issn 1527-8204
1545-293X
1545-293X
language eng
recordid cdi_proquest_miscellaneous_3037398954
source Annual Reviews Open Access
title Polygenic Risk Scores Driving Clinical Change in Glaucoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-21T05%3A50%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Polygenic%20Risk%20Scores%20Driving%20Clinical%20Change%20in%20Glaucoma&rft.jtitle=Annual%20review%20of%20genomics%20and%20human%20genetics&rft.au=Kolovos,%20Antonia&rft.date=2024-08-27&rft.volume=25&rft.issue=1&rft.spage=287&rft.epage=308&rft.pages=287-308&rft.issn=1527-8204&rft.eissn=1545-293X&rft_id=info:doi/10.1146/annurev-genom-121222-105817&rft_dat=%3Cproquest_cross%3E3037398954%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1662-e54f4a4ecf8b4911281bf997a0304105dca05fb677a74af9ff2386aa4860db273%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3037398954&rft_id=info:pmid/38599222&rfr_iscdi=true